Recurring concern

Failure to reliably measure and monitor blood glucose levels

Pin Get email alerts Request correction

First reported 25 Jul 2014•Latest report 13 Jan 2026

Definition

What this concern includes

Includes failures of controls specifically dedicated to measuring, monitoring, reviewing or following up blood glucose levels, including inaccurate measurement, omitted or untimely testing, inadequate trend review and failure to establish whether testing was completed after refusal, across relevant clinical and care settings.

Not included

  • Excludes broader diabetes-care failures where blood-glucose measurement or monitoring is not the identified unsafe condition.
  • Excludes failures limited to prescribing, administering or supplying insulin or other treatment after reliable glucose monitoring has occurred.
  • Excludes generic equipment, staffing, training, documentation or escalation deficiencies unless they directly impair the blood-glucose measurement or monitoring process.
  • Excludes glucose-tolerance testing and other diagnostic testing where the concern is pregnancy-status identification, test-request information or interpretation rather than monitoring blood glucose levels.
Reports
13

Distinct published reports

Individual concerns
18

A report can raise multiple concerns

Date range
2014–2026

First to latest report issue date

Stated actions
19

Described in published responses

Reports over time

Reports over time

Reports about this concern issued each year.

* 2026 is projected from reports observed to 7 Sep 2026.

Most frequent recipients

Most frequent recipients

Reports about this concern sent to each recipient.

Department of Health and Social Care3
Adbolton Hall1
Bank Close House1
Bilbrook Medical Centre1
Blackpool Teaching Hospitals NHS Foundation Trust1
Care Quality Commission1
Four Seasons Health Care Group1
Maidstone and Tunbridge Wells NHS Trust1
Medicines and Healthcare products Regulatory Agency1
National Institute for Health and Care Excellence1
Northern Care Alliance NHS Foundation Trust1
Royal Free London NHS Foundation Trust1
Runwood Homes Limited1
South London and Maudsley NHS Foundation Trust1
Springfield House Nursing Home1

Concerns and responses across reports

Only concerns grouped under this recurring concern are included. Select any concern, action or position to view the source wording.

  1. Black Country

    AI-generated summary

    Eliza Rebecca Bowen · Prevention of Future Deaths report

    This summary was generated using AI from the published report. Please read the original report for the complete account.

    Report summary

    Eliza Bowen, a resident of Springfield House Care Home with complex medical needs, became suddenly unwell on 15 November 2014 and died after developing markedly raised blood glucose, acute kidney injury and metabolic imbalances. The inquest concluded that she died from hyperosmolar non-ketotic coma, a natural cause of death. The principal concerns were that regular blood glucose testing might have identified diabetes sooner and that guidance on diabetes screening and management for patients with relevant risk factors should be available to medical staff.

    Read the report on judiciary.uk

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Failure to perform regular blood glucose testing for patients with diabetes risk factors

    Wider context from the report

    “1. A simple blood glucose test done on a regular basis may have identified the diabetes sooner and the condition managed. 2. Although the patient wasn’t identified as a diabetic she presented with some of the key associated risk factors including BMI greater than 30 and immobility due to her medical condition. ”

    Source location

    Eliza Rebecca Bowen · Prevention of Future Deaths report
    Page 2 · concerns

    Open source report
  2. Inner North London

    AI-generated summary

    Thomas Charles TAYLOR · Prevention of Future Deaths report

    This summary was generated using AI from the published report. Please read the original report for the complete account.

    Report summary

    Thomas Charles Taylor, a diabetic man aged 54, died in the Royal Free Hospital after a delay in administering insulin following the loss of his medical notes and drug chart. Concerns included unclear ward leadership, the absence of a protocol for lost notes and drug charts, inadequate escalation when blood sugar checks were refused, and delayed clinical monitoring after significant hyperglycaemia.

    Read the report on judiciary.uk

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Failure to promptly re-check blood sugar after significant hyperglycaemia

    Wider context from the report

    “3. When Mr Taylor refused to have his blood sugar checked, there seemed no well understood protocol for re-checking or escalation. Immediate provision was not made for the administration of insulin, and a doctor was even told that he was not diabetic. When Mr Taylor became significantly hyperglycaemic on the 22nd, after the administration of the delayed dose of insulin his nurses did not immediately re-check his blood sugar, perform neurological observations or alert medical staff. ”

    Source location

    Thomas Charles TAYLOR · Prevention of Future Deaths report
    Page 2 · concerns

    Open source report

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Lack of a well-understood protocol for rechecking and escalating refused blood glucose checks

    Wider context from the report

    “3. When Mr Taylor refused to have his blood sugar checked, there seemed no well understood protocol for re-checking or escalation. Immediate provision was not made for the administration of insulin, and a doctor was even told that he was not diabetic. When Mr Taylor became significantly hyperglycaemic on the 22nd, after the administration of the delayed dose of insulin his nurses did not immediately re-check his blood sugar, perform neurological observations or alert medical staff. ”

    Source location

    Thomas Charles TAYLOR · Prevention of Future Deaths report
    Page 2 · concerns

    Open source report
  3. Sunderland

    AI-generated summary

    Nathan James Healer · Prevention of Future Deaths report

    This summary was generated using AI from the published report. Please read the original report for the complete account.

    Report summary

    Nathan James Healer was born on 03/02/2014 and died on 05/02/2014 after developing signs including low temperature, poor feeding and jittering arms. His first blood glucose measurement, taken almost five hours after birth, was 0.2 mmol/L. The principal concern was that the severity of his condition was not appreciated and he was not given a more timely blood glucose test, in the context of existing clinical guidance.

    Read the report on judiciary.uk

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Failure to provide timely blood glucose testing for newborns

    Wider context from the report

    “I was made aware of :- a) the 2008 NICE Clinical Guidance 63 “Diabetes in Pregnancy” which in essence recommended a pre 2nd Feed Blood Glucose test at between 2-4 hours; b) the hospital Guidance for “Hypothermia in the newborn Infant” 2014; c) the hospital Guidance for “Prevention, detection and management of hypoglycaemia in the newborn 2012 (Blood glucose test at around 4 hours). Although the severity of Nathans’s condition was not appreciated and he was not given the opportunity of a more timely blood glucose test I heard evidence that although new guidance from NICE is in contemplation it has not yet been finalised. If that is the case then it would be helpful to know what stage this is at and whether any steps can be taken to expedite it’s production. If no new guidance is in contemplation then it may be an opportune moment to revisit the guidance in any event. ”

    Source location

    Nathan James Healer · Prevention of Future Deaths report
    Page 1 · concerns

    Open source report

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Lack of finalized and current guidance on newborn blood glucose testing

    Wider context from the report

    “I was made aware of :- a) the 2008 NICE Clinical Guidance 63 “Diabetes in Pregnancy” which in essence recommended a pre 2nd Feed Blood Glucose test at between 2-4 hours; b) the hospital Guidance for “Hypothermia in the newborn Infant” 2014; c) the hospital Guidance for “Prevention, detection and management of hypoglycaemia in the newborn 2012 (Blood glucose test at around 4 hours). Although the severity of Nathans’s condition was not appreciated and he was not given the opportunity of a more timely blood glucose test I heard evidence that although new guidance from NICE is in contemplation it has not yet been finalised. If that is the case then it would be helpful to know what stage this is at and whether any steps can be taken to expedite it’s production. If no new guidance is in contemplation then it may be an opportune moment to revisit the guidance in any event. ”

    Source location

    Nathan James Healer · Prevention of Future Deaths report
    Page 1 · concerns

    Open source report

    Source evidence

    How this respondent position was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    The imminent NICE guidance review cannot be expedited.

    Verbatim wording from the response

    “Given the imminence of the new guidance, advice from Departmental policy officials is that there is no scope for this process to be expedited. However, as NICE is an independent body, I advise you contact it directly with any further questions you may have about the review of this guidance.”

    Source location

    2014-0343-Response-by-Department-of-Health
    Page 2 · response
    Published 25 July 2014

    Open published response

    Source evidence

    How this respondent position was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Further questions about the guidance review should be directed to NICE, an independent body.

    Verbatim wording from the response

    “Given the imminence of the new guidance, advice from Departmental policy officials is that there is no scope for this process to be expedited. However, as NICE is an independent body, I advise you contact it directly with any further questions you may have about the review of this guidance.”

    Source location

    2014-0343-Response-by-Department-of-Health
    Page 2 · response
    Published 25 July 2014

    Open published response
Back to top

Data last updated 7 September 2026